Last updated 2026-07-27
TL;DR
A certificate of analysis (CoA) confirms a specific batch of azelaic acid or its finished product met identity, potency and purity specs at the time it was tested. It doesn't certify FDA approval, prove clinical efficacy, or guarantee every future batch matches. For prescription Azelex or Finacea, FDA approval already covers manufacturing quality; for compounded or OTC products, ask the pharmacy or brand for the actual CoA, more than a claim that one exists.
What is a certificate of analysis, and why does azelaic acid need one?
A certificate of analysis (CoA) is a lab document tied to one specific manufactured batch (sometimes called a lot) of a raw ingredient or finished product. It lists the tests that were run and the results: appearance, identity confirmation, assay (how much active ingredient is actually present, usually expressed as percent of label claim), impurity levels, microbial limits, and sometimes heavy metal screening. For azelaic acid specifically, the assay result matters more than most ingredients because the whole clinical case for the compound rests on concentration. The FDA-approved products, Azelex (20% cream) and Finacea (15% gel and foam), earned their approval based on trials run at those exact strengths [1][2]. A CoA showing 19.8% versus label claim of 20% is a minor, expected variance. A CoA showing 12% on a product sold as 20% is a real problem, and that's exactly the kind of thing the document is supposed to catch. The CoA is not a marketing claim. It's a quality control record generated by whoever manufactured or tested that batch, whether that's the API (active pharmaceutical ingredient) supplier, a compounding pharmacy, or a cosmetic manufacturer filling OTC serums. If you want to compare strengths before you even get to the sourcing question, our azelaic acid dosage guide walks through what 10%, 15%, and 20% actually mean for you day to day.
What does a real azelaic acid CoA actually show?
| Product/ingredient name | Confirms this is azelaic acid, not a substitute | |
|---|---|---|
| Batch/lot number | Ties the document to one specific production run | |
| Manufacture date and/or expiry | Tells you how old the tested material is | |
| Assay (% purity or % label claim) | The actual concentration measured, e.g. 99.5% pure API, or 20.1% in a finished cream | |
| Appearance/physical description | Color, form (the raw material is a white to off-white crystalline powder) | |
| Microbial limits | Bacterial/fungal counts, relevant mainly for finished topical products | |
| Heavy metals/residual solvents | Impurity ceilings, standard for pharmaceutical-grade API | |
| Testing method reference | Usually a pharmacopeial method (USP, EP) or validated in-house method | |
| Signature/lab identifier | Who actually ran and approved the test | A batch number with no corresponding date, or an assay result with no stated test method, is a red flag. Reputable API suppliers and compounding pharmacies operating under USP standards will show a defined identity and assay method, because azelaic acid has a USP monograph specifying acceptable purity ranges for pharmaceutical-grade material [3]. For a broader sense of where that strength number actually comes from and why it's on the label at all, see our dosage guide. |
A legitimate CoA has a fixed set of fields. If a document is missing most of these, treat it as decorative rather than functional. | Field | What it tells you |
Does a CoA prove a product is FDA approved?
No. A CoA and FDA approval are two different things entirely, and conflating them is the single most common misunderstanding buyers have. FDA approval means a specific drug product, at a specific formulation and strength, went through clinical trials and a regulatory review process, and the agency concluded it's safe and effective for its labeled use. Azelex 20% cream and Finacea 15% gel each have their own FDA approval, covering the exact formulation, manufacturing process, and labeling reviewed at approval time [1][2]. A CoA, by contrast, only confirms that one batch of raw material or finished product met a testing specification. A raw azelaic acid powder can have a clean, professional-looking CoA and still never touch an FDA-regulated finished drug, because it might be destined for a cosmetic serum, a compounded prescription, or an industrial use. The CoA proves batch quality against a spec. It says nothing about whether the finished retail product carries FDA approval, whether it was tested in humans at that formulation, or whether the manufacturing site follows Good Manufacturing Practice (GMP) for drugs on an ongoing basis. If a seller points to a CoA as proof of FDA approval, that's a sign they don't understand the document, or are hoping you won't ask further.
Prescription azelaic acid vs. OTC azelaic acid: does strength on the label match the CoA?
This is where the CoA question actually matters for people comparing options. Prescription strengths are standardized and FDA-verified through the approval process itself: Azelex is 20% azelaic acid cream, Finacea is 15% gel or foam [1][2]. Because these are approved drugs, their manufacturing is subject to ongoing FDA GMP oversight, more than a one-time batch CoA. OTC azelaic acid products, typically marketed around 10% or sometimes labeled higher, are regulated as cosmetics in the US, not drugs, which means there's no FDA premarket review of the formulation or the label's percent claim. Cosmetic companies aren't required to publish CoAs to consumers, and even when a brand claims '10% azelaic acid,' there's no standardized third-party check that the finished bottle actually assays at 10% the way there is for an approved drug. That gap is exactly why a CoA becomes more useful, not less, on the OTC and compounded side. If you're buying a compounded azelaic acid product, ask the pharmacy for the CoA on the raw API they sourced, more than their internal QC statement. A pharmacy that compounds under USP <795> standards for non-sterile preparations should be able to trace their raw material back to a supplier CoA [4].
What can a CoA NOT tell you?
A CoA cannot tell you whether the product will actually clear your acne, fade your melasma, or calm your rosacea. That's a clinical evidence question, answered by trials, not lab assays. It also can't guarantee every future batch matches. A CoA is retrospective: it describes the batch tested, at the time it was tested. Manufacturing drift, storage conditions after shipping, and formulation changes between batches aren't covered by a single certificate. A CoA doesn't verify stability over the product's shelf life either, unless a separate stability study is referenced. Azelaic acid is generally a stable molecule, but finished formulations (creams, gels, foams) can behave differently depending on preservative systems and packaging, and that's a formulation-specific question a batch CoA doesn't answer. Finally, a CoA says nothing about bioavailability or penetration, meaning how much of that verified 20% concentration actually gets into the skin where it needs to act. That depends on vehicle (cream vs. gel vs. foam) and is a formulation and clinical question, not a lab-purity one.
What's the clinical evidence for azelaic acid, and does concentration matter to outcomes?
Azelaic acid has one of the better evidence bases among topical acne and rosacea treatments, and concentration does track with the trial data used for approval. For acne, azelaic acid works through several mechanisms: it's mildly comedolytic, has antibacterial activity against P. acnes (now called Cutibacterium acnes), and has some effect on post-inflammatory hyperpigmentation. Azelex 20% cream was FDA approved based on trials in mild to moderate acne, and its prescribing information describes efficacy comparable to some other topical acne agents in head-to-head data [1]. For rosacea, Finacea 15% gel is FDA approved specifically for the inflammatory papules and pustules of rosacea, based on trials showing significant reduction in lesion counts versus vehicle [2]. Multiple randomized trials support azelaic acid 15-20% for rosacea as a mainstay topical option in the dermatology literature [5]. For melasma and post-inflammatory hyperpigmentation, azelaic acid has real trial support too. A double-blind trial comparing azelaic acid 20% cream to 4% hydroquinone found comparable efficacy for melasma over 24 weeks, with azelaic acid causing less irritation in certain patients [6]. It's considered one of the reasonable alternatives for patients who can't or don't want to use hydroquinone. The honest caveat: most of the strongest efficacy data is at 15-20% concentrations, the prescription range. OTC 10% products have far less dedicated trial data behind that specific concentration; the assumption that '10% still works, just more gently' is reasonable pharmacologically but isn't backed by the same volume of head-to-head trials as the approved strengths.
Is azelaic acid safe in pregnancy, and what side effects should I expect regardless of CoA?
Azelaic acid is one of the more reassuring topical options during pregnancy among acne and rosacea treatments, which is part of why dermatologists reach for it often in that population. Finacea's prescribing information notes that systemic absorption is low and that available data have not shown it increases the risk of major birth defects, though it also notes the data are limited, and any decision should involve your prescriber [2]. Side effects are common but almost always mild and self-limited. Expect transient stinging, burning, tingling, or itching in the first days to weeks of use, especially on the gel formulation, which tends to sting more than the cream. Redness, dryness and mild peeling are also reported. In the Finacea trials, itching and burning were among the more frequently reported application-site reactions [2]. None of this is related to whether you have a CoA in hand. Tolerability is about formulation and individual skin sensitivity, not batch purity. A perfectly clean CoA doesn't mean you won't sting for the first two weeks; that's just how azelaic acid tends to feel going on, particularly at higher concentrations or on already-irritated rosacea skin. If you're also on other topicals or oral medications, our drug interactions guide covers what actually needs a second look before you combine anything.
How do I ask a pharmacy or brand for a CoA, and what should I do if they refuse?
Ask directly and specifically: request the CoA for the batch or lot number printed on your product, not a generic template CoA the company keeps on file for marketing. A generic CoA with no lot number tied to your actual bottle is close to meaningless, because it doesn't prove your specific product matches that data. A reasonable pharmacy or compounding facility should be able to provide, or at least reference, the CoA for the raw API used in your prescription, plus confirmation of the compounding process. If you're going through a licensed provider-reviewed pathway, dosing guidance and strength options are usually easier to sort out upfront than after the fact, since strength (10%, 15%, 20%) drives both efficacy expectations and tolerability. Our own dosage breakdown is a reasonable starting point for that conversation. If a seller stalls, gives vague answers, or claims 'we don't have that information' for a prescription-strength claim, that's worth treating as a real caution flag. It doesn't necessarily mean the product is fake, but it does mean you can't verify what you're told is accurate, and for a topical you're putting on your face for months, that's a reasonable thing to want verified.
How does Azelaic Acid handle sourcing and quality documentation?
Azelaic Rx doesn't compound or manufacture azelaic acid products itself. It operates as a provider-reviewed pathway: a licensed prescriber reviews your history and, where azelaic acid is appropriate, the prescription is fulfilled through a partner pharmacy that handles the actual dispensing and quality documentation, including sourcing records tied to the batches they use. That separation matters for CoA questions specifically. The manufacturing and lot-level quality control sits with the pharmacy, not with the review platform, so if you want batch-specific documentation, that's the party to ask. A provider-reviewed model doesn't replace a CoA; it adds a clinical check (is azelaic acid the right call for your skin, at what strength, alongside what else) on top of whatever quality documentation the fulfilling pharmacy maintains.
How does azelaic acid CoA scrutiny compare to other topical actives?
| Azelex 20% (Rx) | FDA-approved NDA, ongoing GMP oversight | High baseline assurance; CoA mainly a manufacturing-side QC record | |
|---|---|---|---|
| Finacea 15% (Rx) | FDA-approved NDA, ongoing GMP oversight | Same as above | |
| Compounded azelaic acid (Rx, various %) | State board of pharmacy oversight, USP <795> standards | CoA on raw API is the main external quality check available to you | |
| OTC azelaic acid ~10% | Cosmetic regulation, no FDA premarket review of formulation | CoA (if offered at all) is voluntary; no standardized enforcement | The practical takeaway: the further a product sits from an FDA-approved NDA, the more the CoA (or its absence) actually tells you something you couldn't otherwise verify. For Azelex or Finacea, you're relying on the approval and ongoing GMP framework more than any single CoA. For compounded or OTC azelaic acid, the CoA (or a pharmacy's willingness to produce one) is close to the only external quality signal you get. If drug interactions are part of your decision too, our drug interactions guide covers what actually matters to check before starting, and the dosage guide covers how strength choice fits into that. |
Azelaic acid isn't unusually risky to source compared to other common dermatology actives, but it's also not immune to the same OTC gray zone that affects things like tretinoin analogs or high-strength vitamin C serums. | Product type | Regulatory oversight | CoA relevance |
Frequently asked questions
What is a certificate of analysis for azelaic acid?
It's a batch-specific lab document showing test results for identity, potency (assay), purity, and sometimes microbial limits for one manufactured lot of azelaic acid or a finished product containing it. It confirms what that particular batch measured at, not what every bottle will measure.
Does a CoA mean the product is FDA approved?
No. A CoA is a quality control record for one batch. FDA approval is a separate regulatory status covering an entire drug product's formulation, based on clinical trials, that only applies to specific approved products like Azelex 20% and Finacea 15% [1][2].
What azelaic acid strength is FDA approved?
Azelex is FDA approved at 20% cream for acne; Finacea is FDA approved at 15% gel and foam for rosacea [1][2]. OTC products typically sit around 10% and are regulated as cosmetics, without the same premarket review of the formulation.
Is 10% azelaic acid as effective as 15% or 20%?
There's less dedicated trial data at 10%, since the major acne and rosacea trials were run at 15-20%. Pharmacologically a lower concentration likely works somewhat, just more gently, but that's an inference, not a directly tested claim in the same trials [1][2].
Can azelaic acid help with melasma or dark spots?
Yes, there's real trial support. A double-blind study found azelaic acid 20% cream produced results comparable to 4% hydroquinone for melasma over 24 weeks, with less irritation reported in certain patients, making it a reasonable alternative for people who want to avoid hydroquinone [6].
What side effects should I expect from azelaic acid regardless of the CoA?
Transient stinging, burning, tingling, redness, or mild peeling in the first days to weeks, more common with gel than cream. These are formulation and individual-tolerance effects, unrelated to batch purity or CoA status [2].
Is azelaic acid safe during pregnancy?
Available data on Finacea have not shown increased risk of major birth defects, and systemic absorption is low, but data are limited and the prescribing information recommends discussing use with your prescriber rather than assuming safety outright [2].
How do I request a CoA from a pharmacy or brand?
Ask for the CoA tied to the specific lot or batch number on your product, not a generic template. A compounding pharmacy should be able to reference the raw API supplier's CoA; a brand selling OTC serums may or may not have one on file, since it isn't legally required for cosmetics.
What's the difference between Azelex and Finacea?
Azelex is a 20% cream FDA approved for acne. Finacea is a 15% gel or foam FDA approved for rosacea. Both contain azelaic acid at different concentrations and in different vehicles, each approved for its own primary indication [1][2].
Does azelaic acid interact with other medications?
Significant systemic drug interactions are uncommon given azelaic acid's low systemic absorption, but topical combinations (with retinoids or other actives) can increase irritation. See our drug interactions guide for specifics before combining products.
Can a CoA guarantee every bottle I buy will be identical?
No. A CoA describes the batch tested at the time of testing. It doesn't cover future batches, storage-related degradation after shipping, or formulation changes, so it's a snapshot, not an ongoing guarantee.
Is compounded azelaic acid regulated the same way as Azelex or Finacea?
No. Compounded preparations fall under state board of pharmacy oversight and USP <795> non-sterile compounding standards rather than FDA's drug approval pathway, so there's no clinical trial behind the specific compounded formulation, even if the raw API itself is high quality [4].
Sources
- FDA, Azelex (azelaic acid cream) 20% prescribing information, NDA 020428: Azelex 20% cream is FDA approved for acne based on clinical trial data
- FDA, Finacea (azelaic acid gel) 15% prescribing information, NDA 021470: Finacea 15% gel is FDA approved for rosacea, including pregnancy and side effect data
- United States Pharmacopeia, Compounding compendium overview: Pharmaceutical-grade azelaic acid purity is defined by a USP monograph standard
- United States Pharmacopeia, General Chapter <795> Pharmaceutical Compounding - Nonsterile Preparations: Compounding pharmacies operate under USP <795> standards for nonsterile preparations
- National Center for Biotechnology Information, StatPearls, Rosacea treatment overview: Azelaic acid 15% gel is a recognized topical treatment for papulopustular rosacea
- PubMed, Balina LM, Graupe K. The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol. 1991: Azelaic acid 20% cream showed efficacy comparable to 4% hydroquinone for melasma with less irritation in some patients